Search results
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals...
Benzinga· 1 day agoLoading... Loading... Throughout the last three months, 14 analysts have evaluated Regeneron Pharmaceuticals REGN , offering a diverse set of opinions from bullish to bearish ...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) the Best Bet in Gene Therapy Industry?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we...
Buy Alert: 3 Penny Stocks That Will Explode in 2024
InvestorPlace· 7 hours agoWhen the term penny stocks to buy is thrown around, ideas of high-risk-high-reward, overnight wealth generation and potential scams may come to mind....
Leonard Schleifer
Fortune· 1 day agoRegeneron is a research-oriented biotech, founded by Schleifer, that had no product on the market for its first 20 years. Today its monoclonal antibodies, particularly Eylea ...
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 5 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
What's Going On With FibroGen Stock Tuesday? - FibroGen (NASDAQ:FGEN)
Benzinga· 22 hours agoFibroGen also announced a new clinical trial supply agreement with Regeneron. The Details: FibroGen...
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
Morningstar· 5 days agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted ...
FDA delays decision on Dupixent in COPD; Summit makes a bold claim
BioPharma Dive via Yahoo Finance· 5 days agoRegeneron and Sanofi now expect an FDA verdict in September. Elsewhere, Summit claimed victory over...
Regeneron Pharmaceuticals Inc TradeGate Stock Price Today | NASDAQ REGN Live Ticker - Investing.com
Investing.com· 5 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 7 hours agoTaking into account individual holdings, Gilead Sciences Inc (GILD) accounts for about 8.31% of the...
